Skip to content

Transfusion Strategies for Pediatric Liver Transplantation

The Perioperative Liberal or Restrictive Transfusion in Pediatric Liver Transplantation: A Prospective Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02951013
Enrollment
488
Registered
2016-11-01
Start date
2016-12-07
Completion date
2022-12-30
Last updated
2021-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Patients Who Need Liver Transplantation

Brief summary

The patients assigned to the restrictive group will receive transfusion once the hemoglobin concentration falls below 6.0 g per deciliter, with a target hemoglobin range of 7.5 to 8.0 g per deciliter. Patients assigned to the liberal group will receive transfusion once the hemoglobin concentration falls below 8.0 g per deciliter, with a target hemoglobin range of 9.0 to 10.0 g per deciliter. The primary outcome: Survival rate in six months after randomization. Secondary outcomes: Incidence of perioperative complications, including sepsis , pulmonary complications, portal vein thrombosis, hepatic artery thrombosis and transfusion-related adverse events. Intraoperative blood loss, intraoperative blood transfusion amount, postoperative blood transfusion amount in 7 days after surgery, postoperative inflammatory reaction, mechanical ventilation time in the intensive care unit, lengths of stay in the intensive care unit and the hospital,and hospitalization expenses.

Interventions

Transfusion will start when the hemoglobin concentration falls below 6.0 g/dL

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 36 Months
Healthy volunteers
No

Inclusion criteria

* The investigators study included pediatric patients (the moon's age \<36 months) who will receive standard living-donor liver transplantation (LDLT) in Renji Hospital.

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frame
Survival rateup to 6 months after randomization

Secondary

MeasureTime frameDescription
Amount of blood transfusion during perioperative periodup to 7 days after surgery
Heart rate during surgeryduring surgery
Blood pressure during surgeryduring surgery
Arterial partial pressure of oxygen during surgeryduring surgery
Plasma lactic acid concentration during surgeryduring surgery
Oxygen uptake rate during surgeryduring surgery
Amount of intraoperative blood transfusionduring surgery
Length of Mechanical Ventilation in the intensive care unitat discharge, an average of 2 weeks
Lengths of stay in the intensive care unitat discharge, an average of 2 weeks
Proportion of patients who need a second hepatic surgeryup to 7 days after randomization
Hospitalization Daysat discharge, an average of 2 weeks
Out of pocket expenditure for hospitalizationat discharge, an average of 2 weeks
Incidence of severe postoperative complications before dischargefrom end of surgery till at discharge, an average of 2 weeksPostoperative complications include sepsis , pulmonary complications, portal vein thrombosis, hepatic artery thrombosis and transfusion-related adverse events.
Daily score on Pediatric end-stage liver disease (PELD) assessmentup to 7 days after randomization

Countries

China

Contacts

Primary ContactJie Tian
vaseline2001@hotmail.com862168383702

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026